Insider Trading activities of Reva Medical, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Reva Medical, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Reva Medical, Inc. since year 2005. Table 2 shows the detailed insider transactions of Reva Medical, Inc. since 2005. The reporting company's ticker symbol is RVA:AX. The reporting company's CIK number is 1496268.
The total value of stock buying since 2005 is $1,516,664.
The total value of stock sales since 2005 is $51,685,153.
The total value of stock option exercises since 2005 is $9,915,789.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Reva Medical, Inc. (RVA:AX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-08 2,378 $14,029 0 $0 0 $0
2017-05 0 $0 55,000 $366,300 0 $0
2016-07 73,242 $546,228 0 $0 0 $0
2016-06 2,500 $19,465 9,999 $75,983 0 $0
2016-03 10,425 $88,414 0 $0 0 $0
2015-12 0 $0 4,500 $26,986 0 $0
2015-11 0 $0 5,000 $27,970 0 $0
2015-10 0 $0 0 $0 4,375,000 $9,493,750
2015-09 0 $0 9,999 $46,114 0 $0
2015-07 0 $0 0 $0 90,000 $112,500
2015-06 7,250 $29,090 0 $0 0 $0
2015-05 10,000 $38,460 0 $0 0 $0
2015-03 0 $0 0 $0 50,000 $62,500
2014-12 0 $0 9,999 $36,271 0 $0
2014-11 30,550 $95,012 0 $0 0 $0
2014-10 0 $0 0 $0 5,000 $5,000
2014-09 0 $0 0 $0 43,575 $51,236
2014-01 0 $0 0 $0 142,150 $134,905
2013-12 35,246 $156,366 10,000 $44,070 0 $0
2013-11 0 $0 0 $0 20,000 $12,200
2013-05 0 $0 0 $0 27,850 $16,988
2012-09 3,000 $16,169 10,000 $54,330 0 $0
2012-08 7,000 $39,680 0 $0 10,000 $10,000
2012-06 10,854 $67,735 7,500 $44,797 0 $0
2012-05 10,000 $64,743 12,450 $80,219 0 $0
2012-03 0 $0 9,832,537 $50,882,113 0 $0
2012-02 0 $0 0 $0 20,000 $16,100
2011-10 0 $0 0 $0 1,000 $610
2011-08 38,300 $241,274 0 $0 0 $0
2010-12 90,909 $99,999 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Reva Medical, Inc. insiders (RVA:AX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-08-29 Groves Regina E (Chief Executive Officer) Buy 386 6.37 2,458
2017-08-23 Groves Regina E (Chief Executive Officer) Buy 407 6.37 2,592
2017-08-21 Groves Regina E (Chief Executive Officer) Buy 402 5.86 2,357
2017-08-17 Kimes Richard M. (Senior VP, Operations) Buy 880 5.61 4,935
2017-08-17 Groves Regina E (Chief Executive Officer) Buy 303 5.57 1,687
2017-05-17 Schultz Robert K. (President & COO) Sale 55,000 6.66 366,300
2016-07-21 Breckenridge Ross (Director) Buy 1,773 7.34 13,008
2016-07-21 Nye Gordon E (Director) Buy 3,354 7.34 24,608
2016-07-15 Groves Regina E (Chief Executive Officer) Buy 2,683 7.45 19,996
2016-07-15 Keating Anne (Director) Buy 15,306 7.47 114,397
2016-07-15 Thomas Robert Bain (Director) Buy 30,000 7.47 224,220
2016-07-14 Stockman Robert Bernard (Director) Buy 20,126 7.45 149,999
2016-06-28 Brandom Donald K. (SVP, Product Development) Sale 994 7.33 7,282
2016-06-24 Brandom Donald K. (SVP, Product Development) Sale 3,079 7.36 22,673
2016-06-23 Brandom Donald K. (SVP, Product Development) Sale 926 7.79 7,218
2016-06-17 Brandom Donald K. (SVP, Product Development) Sale 5,000 7.76 38,810
2016-06-17 Thomas Robert Bain (Director) Buy 2,500 7.79 19,465
2016-03-31 Thomas Robert Bain (Director) Buy 2,500 8.42 21,057
2016-03-30 Groves Regina E (Chief Executive Officer) Buy 925 8.60 7,956
2016-03-29 Kimes Richard M. (Senior VP, Operations) Buy 500 8.39 4,197
2016-03-29 Stockman Robert Bernard (Director) Buy 6,500 8.49 55,204
2015-12-04 Anderson Jeffrey A. (SVP, Clinical & Regulatory) Sale 4,500 6.00 26,986
2015-11-17 Brandom Donald K. (SVP, Product Development) Sale 5,000 5.59 27,970
2015-10-02 Taylor Nicholas (10% Owner) Option Ex 4,375,000 2.17 9,493,750
2015-09-21 Brandom Donald K. (SVP, Product Development) Sale 6,162 4.41 27,168
2015-09-18 Brandom Donald K. (SVP, Product Development) Sale 200 4.28 855
2015-09-10 Brandom Donald K. (SVP, Product Development) Sale 1,137 4.66 5,301
2015-09-03 Brandom Donald K. (SVP, Product Development) Sale 2,500 5.12 12,790
2015-07-07 Schultz Robert K. (President & COO) Option Ex 80,000 1.25 100,000
2015-07-01 Zeltinger Joan K. (VP, Scientific Affairs) Option Ex 10,000 1.25 12,500
2015-06-04 Breckenridge Ross (Director) Buy 1,000 4.09 4,090
2015-06-03 Stockman Robert Bernard (Chairman and CEO) Buy 6,250 4.00 25,000
2015-05-28 Thomas Robert Bain (Director) Buy 10,000 3.85 38,460
2015-03-10 Brandom Donald K. (SVP, Product Development) Option Ex 50,000 1.25 62,500
2014-12-12 Brandom Donald K. (SVP, Product Development) Sale 6,312 3.52 22,186
2014-12-11 Brandom Donald K. (SVP, Product Development) Sale 596 3.77 2,243
2014-12-09 Brandom Donald K. (SVP, Product Development) Sale 3,000 3.83 11,481
2014-12-08 Brandom Donald K. (SVP, Product Development) Sale 91 3.98 361
2014-11-21 Stockman Robert Bernard (Chairman and CEO) Buy 25,000 3.19 79,750
2014-11-20 Stockman Robert Bernard (Chairman and CEO) Buy 5,550 2.75 15,262
2014-10-20 Anderson Jeffrey A. (SVP, Clinical & Regulatory) Option Ex 5,000 1.00 5,000
2014-09-18 Thompson Katrina (CFO & Secretary) Option Ex 23,575 1.32 31,236
2014-09-10 Zeltinger Joan K. (VP, Scientific Affairs) Option Ex 20,000 1.00 20,000
2014-01-09 Brandom Donald K. (VP, Product Development) Option Ex 37,150 .81 29,905
2014-01-09 Schultz Robert K. (President & COO) Option Ex 85,000 1.00 85,000
2014-01-09 Thompson Katrina (CFO & Secretary) Option Ex 20,000 1.00 20,000
2013-12-13 Nye Gordon E (Director) Buy 9,600 4.65 44,640
2013-12-10 Brandom Donald K. (VP, Product Development) Sale 5,805 4.41 25,571
2013-12-10 Stockman Robert Bernard (Chairman and CEO) Buy 11,500 4.49 51,635
2013-12-10 Thomas Robert Bain (Director) Buy 2,500 4.60 11,500
2013-12-09 Brandom Donald K. (VP, Product Development) Sale 4,195 4.41 18,499
2013-12-09 Thompson Katrina (CFO & Secretary) Buy 4,146 4.43 18,366
2013-12-06 Thomas Robert Bain (Director) Buy 7,500 4.03 30,225
2013-11-12 Zeltinger Joan K. (VP, Scientific Affairs) Option Ex 20,000 .61 12,200
2013-05-13 Brandom Donald K. (VP, Product Development) Option Ex 27,850 .61 16,988
2012-09-13 Anderson Jeffrey A. (VP, Clinical & Regulatory) Sale 10,000 5.43 54,330
2012-09-13 Thomas Robert Bain (Director) Buy 3,000 5.39 16,169
2012-08-28 Thomas Robert Bain (Director) Buy 2,000 5.60 11,200
2012-08-24 Thomas Robert Bain (Director) Buy 3,000 5.64 16,920
2012-08-23 Thomas Robert Bain (Director) Buy 2,000 5.78 11,560
2012-08-16 Anderson Jeffrey A. (VP, Clinical & Regulatory) Option Ex 10,000 1.00 10,000
2012-06-13 Thompson Katrina (CFO & Secretary) Buy 854 6.54 5,585
2012-06-12 Thomas Robert Bain (Director) Buy 5,000 6.43 32,150
2012-06-05 Anderson Jeffrey A. (VP, Clinical & Regulatory) Sale 7,500 5.97 44,797
2012-06-04 Thomas Robert Bain (Director) Buy 5,000 6.00 30,000
2012-05-30 Anderson Jeffrey A. (VP, Clinical & Regulatory) Sale 2,500 6.56 16,400
2012-05-30 Thomas Robert Bain (Director) Buy 3,150 6.46 20,364
2012-05-25 Brandom Donald K. (VP, Product Development) Sale 2,400 6.48 15,552
2012-05-25 Thomas Robert Bain (Director) Buy 5,000 6.53 32,650
2012-05-24 Brandom Donald K. (VP, Product Development) Sale 7,550 6.39 48,267
2012-05-24 Thomas Robert Bain (Director) Buy 1,850 6.34 11,729
2012-03-23 Schoemaker Kathleen K (10% Owner) Sale 1,695,717 5.16 8,749,899
2012-03-23 Dovey Brian H (Director) Sale 1,695,717 5.16 8,749,899
2012-03-23 Domain Partners V Lp (10% Owner) Sale 1,656,581 5.16 8,547,957
2012-03-23 Dp V Associates Lp (10% Owner) Sale 39,136 5.16 201,941
2012-03-23 Blair James C (10% Owner) Sale 1,695,717 5.16 8,749,899
2012-03-23 Treu Jesse I (10% Owner) Sale 1,695,717 5.16 8,749,899
2012-03-18 Saints Capital Everest Lp Sale 1,353,952 5.27 7,132,619
2012-02-29 Anderson Jeffrey A. (VP, Clinical & Regulatory) Option Ex 10,000 1.00 10,000
2012-02-14 Brandom Donald K. (VP, Product Development) Option Ex 10,000 .61 6,100
2011-10-12 Schmid Eric V. (VP of Advanced Technology) Option Ex 1,000 .61 610
2011-08-29 Schultz Robert K. (President & COO) Buy 5,000 6.77 33,850
2011-08-24 Stockman Robert Bernard (Chairman and CEO) Buy 25,000 6.29 157,250
2011-08-23 Keating Anne (Director) Buy 3,300 6.28 20,724
2011-08-19 Thomas Robert Bain (Director) Buy 5,000 5.89 29,450
2010-12-16 Saints Capital Everest Lp (10% Owner) Buy 90,909 1.10 99,999

Insider trading activities including stock purchases, stock sales, and option exercises of RVA:AX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Reva Medical, Inc. (symbol RVA:AX, CIK number 1496268) see the Securities and Exchange Commission (SEC) website.